Antibody-Drug Conjugate RC48 Ignites Ferroptosis to Rally Immune Cells Against HER2 Breast Cancer
New research shows the anti-HER2 antibody-drug conjugate disitamab vedotin kills breast cancer cells through ferroptosis, releasing danger signals that activate ...

